No Data
No Data
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading
MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock?
Cantor Fitzgerald Maintains Mereo BioPharma(MREO.US) With Buy Rating, Maintains Target Price $7
Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference
AM Best Assigns Credit Ratings to Mereo Insurance Limited